• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT XL VASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT XL VASCULAR STENT Back to Search Results
Catalog Number EX061703C
Device Problems Occlusion Within Device (1423); Dent in Material (2526); Material Torqued (2980); Material Twisted/Bent (2981)
Patient Problems Occlusion (1984); Vascular System (Circulation), Impaired (2572)
Event Date 11/30/2015
Event Type  Injury  
Manufacturer Narrative
The device history records are being reviewed.The event is currently under investigation.Although this product is not sold in the u.S., this event is being reported under regulation 21cfr part 803 as it involves a similar device to a pma approved device sold in the u.S.Under # (b)(4).The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported that two stents were placed in overlapping technique in the sfa and that the distal stent was found dented three days after placement.Furthermore, the vessel was found occluded.Thrombectomy, balloon dilation, further stent placement and lysis were performed to treat the patient.After lysis the patient was found free of thrombus and free of stenosis.This complaint addresses the stent in distal position.
 
Manufacturer Narrative
The lot history records have been reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met all specifications prior to shipment.There is no indication for a manufacturing-related failure.Based on the images and video clips provided it is confirmed that two stents were placed in overlapping manner and that the stent in distal position was found twisted three days after placement.The stented section was found occluded.Potential factors that could have led or contributed to the event reported have been evaluated.Therefore previous investigations of similar complaints have been reviewed.A root cause analysis for the failure mode of twisted stents has been previously performed to determine the root cause for this kind of event.Based on the root cause analysis performed, twisting of this kind of stent is caused by interactions of various use related and anatomical factors with the given stent design.Due to the helical structure the stent has an inherent tendency to rotate clockwise upon deployment of the delivery system.The failure mode may occur when this rotational movement is constricted during stent deployment or when rotational forces are applied externally on the stent.There may be also various physical forces, including individual patient factors, contributing to the twisting of a stent in this region.In this case no issues were reported during the initial stent placement.As reported the lesion was pre dilated and post dilated.Based on the information available and the evaluation of the images provided, a definite root cause could not be determined.In reviewing the labeling supplied with this product it was found that the ifu sufficiently describe the correct deployment of the stent.The ifu states: 'to ensure the most accurate placement, firmly hold the black system stability sheath throughout deployment (.) do not hold the silver stent delivery sheath at any time during deployment.Do not constrict the stent delivery sheath during stent deployment (.) initiate stent deployment by rotating the thumbwheel in the direction of the arrows while holding the handle in a fixed position (.) while maintaining a fixed handle position, rotate thumbwheel to obtain initial stent wall apposition of 1cm minimum (.) with distal end of the stent apposing the vessel wall, deployment continues with the following method (.) while maintaining a fixed handle position, place your finger in front of the deployment slide and slide it from the distal to proximal end.' the ifu also mentions balloon pre and post dilation: 'post stent expansion with a pta catheter is recommended.' and 'predilation of the lesion should be performed using standard techniques.' (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFESTENT XL VASCULAR STENT
Type of Device
VASCULAR STENT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstrasse 6
karlsruhe 76227
GM  76227
Manufacturer (Section G)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG -9681442
wachhausstrasse 6
karlsruhe 76227
GM   76227
Manufacturer Contact
frank kirchner
wachhausstrasse 6
karlsruhe 76227
GM   76227
0497219445
MDR Report Key5339713
MDR Text Key34912601
Report Number9681442-2016-00003
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeGM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,study
Reporter Occupation Radiologic Technologist
Type of Report Initial,Followup
Report Date 12/04/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/02/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2017
Device Catalogue NumberEX061703C
Device Lot NumberANZF2962
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Event Location Hospital
Date Manufacturer Received02/04/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/17/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age71 YR
Patient Weight55
-
-